Florida Theranostics is built upon the foundation of precision medicine, committed to delivering efficient, precise, and empathetic treatment to every patient we serve. Our goal is to be at the forefront of the radioligand therapy and molecular imaging field of medicine, establishing ourselves as a top leader in the south Florida region. We believe leveraging cutting-edge technologies such as the United Imaging uMI Panorama PET/CT and the Veriton 400 SPECT-CT will bring us closer to achieving that goal
Imaging service line
PET-CT IMAGING
POSITRON EMISSION TOMOGRAPHY - COMPUTERIZED TOMOGRAPHY
Amyloid PET Brain Alzheimer's
Amyloid PET visualizes the build-up of amyloid plaques in the brain, a hallmark of Alzheimer's disease and other neurodegenerative disorders. The scan helps differentiate Alzheimer's from other forms of dementia and can aid in selecting patients for specific therapies, including those targeting amyloid plaques
PSMA PET-CT Prostate cancer
Ga-68 PSMA (Illucix™ ) F-18 PSMA ( Pylarify™ or Posluma™ )
can be used to detect and diagnose prostate cancer, particularly in cases where the cancer may have spread or recurred. This PET tracer targets a protein called PSMA (prostate-specific membrane antigen), which is overexpressed by prostate cancer cells and their metastases.
F-18 FDG Oncology
F-18 FDG-PET stands for Fluorodeoxyglucose-Positron Emission Tomography, an imaging technique that uses radioactive glucose analog to visualize metabolic activity within the body. It's primarily used in oncology (cancer imaging) but also has applications in other areas like cardiology and neurology, infection and inflammation.
DOTATATE PET Neuroendocrine tumors, Meningiomas, Pheochromocytomas
This advanced imaging technique utilizes a special radioactive tracer to help detect and diagnose neuroendocrine tumors (NETs)., meningiomas, and rare pheochromocytomas by targeting the somatostatin-receptors (SSTR) which are overexpressed in these conditions.
FES-PET Cerianna™ in ER+ve Breast cancer
This special imaging technique uses a radioactive tracer called fluoroestradiol to visualize the body's estrogen receptors. It's particularly useful in diagnosing and monitoring hormone receptor-positive breast cancer, especially when standard imaging methods are inconclusive or biopsy is challenging.
F-18 Flurpiridaz FLYRCARDO™ Myocardial perfusion
Flurpiridaz F-18 is used for myocardial perfusion imaging to diagnose and evaluate coronary artery disease (CAD). It is a relatively new tracer that has been approved by the FDA for use in patients with known or suspected CAD. It is designed to improve the detection of CAD and provides a more accurate assessment of myocardial blood flow.
SPECT-CT nuclear medicine imaging
SPECT-CT (Single-Photon Emission Computed Tomography - Computed Tomography) imaging combines the functional imaging of SPECT with the anatomical detail of CT. These scans provide both functional and anatomical information. They use radioactive tracers to show how organs and tissues are working, while CT provides detailed anatomical images. This allows for more precise diagnosis and localization of abnormalities, especially in conditions like cancer, heart ailments, neurological
DATscan Parkinson's
DaTscan is a brain scan that uses a radioactive tracer to visualize dopamine transporters, which are proteins that transport dopamine into brain cells. It's primarily used to help diagnose Parkinson's disease and other parkinsonian syndromes
Thyroid scan and uptake
Radioactive iodine uptake test (RAIU) evaluates thyroid function and identify abnormalities like thyroid nodules, goiter, or overactive or underactive thyroid glands. The test helps determine if the thyroid is working properly, diagnose thyroid problems, and evaluate the effects of treatment.
Parathyroid Sestamibi SPECT-CT
A parathyroid sestamibi scan helps pinpoint the location of an overactive parathyroid gland, especially before surgery to remove it.